Monotherapy often fails to solve complex, multifactorial disease problems. The authors argued that combining acupuncture-medicine combination therapy with conventional pharmacotherapy can address therapeutic gaps. They reported that integrated models aim to increase clinical efficacy while reducing adverse effects, by leveraging the different strengths of each modality. The paper framed the combination approach as an alternative strategy when single treatments produce suboptimal outcomes or unacceptable toxicity. The review is a conceptual synthesis rather than a report of new clinical trials.
The review team constructed a working theoretical model anchored on the concepts of supplementation and regulation. In this formulation, acupuncture contributes physiological modulation and homeostatic balance, while pharmacotherapy provides targeted biochemical interventions. The authors presented supplementation as one pathway—acupuncture supplies functional support where drugs leave deficits—and regulation as the other, where acupuncture modulates systemic responses to restore equilibrium. The abstract did not include operationalized criteria, experimental protocols, or specific clinical algorithms; those details were not reported in the summary available.
Investigators reported two conceptually distinct routes by which combined therapy may boost therapeutic effect. First, same-effect reinforcement (the review described this as “same-effect mutual requirement”) refers to situations where acupuncture and a drug act on overlapping pathways, producing additive or reinforcing outcomes. Second, different-effect complementarity means each modality addresses separate but related pathophysiologic mechanisms, so their joint application covers a broader therapeutic target range than either alone. The authors discussed these mechanisms at a theoretical level—explaining physiological plausibility and mechanistic logic—rather than presenting quantitative measures of effect size, controlled trial results, or head-to-head comparisons. The English abstract and MeSH indexing emphasize treatment outcome and adverse effects but do not supply numerical efficacy data.
The review analyzed characteristics of toxicity reduction through the lens of antagonistic or counteracting mechanisms. In this view, acupuncture may blunt, offset, or regulate pathways that mediate a medication’s adverse effects—thereby reducing toxicity without compromising efficacy. The authors described conceptual examples of how counter-regulatory neural, autonomic, or immunologic effects of acupuncture could mitigate drug-related harm. The abstract did not present clinical safety endpoints, rates of adverse events, or pharmacokinetic details; such empirical data were not reported in the abstract available on PubMed.
The article, as summarized, focused on theoretical patterns and mechanistic discussion. The abstract did not report randomized controlled trial results, cohort sizes, dosing regimens, statistical outcomes, or specific clinical conditions where the combined approach had been tested. Investigators did not provide methodological specifics in the English abstract accessible through PubMed. Therefore, readers should consider this a conceptual review that synthesizes prior literature and proposes hypotheses rather than furnishing new primary efficacy or safety data.
The authors stated their objective: to provide a theoretical foundation and propose future research directions for acupuncture-medicine combination therapy. They called attention to the need for further study to translate conceptual mechanisms into testable clinical protocols. The review lists keywords—antagonistic effects, enhanced efficacy and reduced toxicity, synergistic effects—which indicate priority topics for empirical follow-up. The paper appears in Zhen Ci Yan Jiu; it is a review with an English abstract, authored by Nana Yang, Yiduo Liu, and Cunzhi Liu from the School of Acupuncture-Moxibustion and Tuina at Beijing University of Chinese Medicine (PMID 42908457; DOI 10.13702/j.1000-0607.20250993). The authors declared no conflicts of interest.
Limitations explicitly reflected in the PubMed abstract include the lack of reported quantitative clinical outcomes and the absence of detailed methodological parameters in the abstract. The review therefore leaves several unanswered clinical questions that require primary research: which disease states most benefit from the combination approach; what standardized acupuncture protocols should be paired with specific drug regimens; and whether reproducible reductions in adverse events can be demonstrated in randomized trials. These unanswered questions, noted by the authors as areas for future research, are the next concrete steps documented in the source.